Heritage Wealth Advisors’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-500
| Closed | -$3.95K | – | 580 |
|
|
2022
Q3 | $3.95K | Hold |
500
| – | – | ﹤0.01% | 459 |
|
|
2022
Q2 | $11K | Hold |
500
| – | – | ﹤0.01% | 460 |
|
|
2022
Q1 | $19K | Hold |
500
| – | – | ﹤0.01% | 403 |
|
|
2021
Q4 | $28K | Buy |
+500
| New | +$28K | ﹤0.01% | 380 |
|
|
2021
Q2 | – | Sell |
-250
| Closed | -$37K | – | 592 |
|
|
2021
Q1 | $37K | Sell |
250
-200
| -44% | -$29.6K | ﹤0.01% | 359 |
|
|
2020
Q4 | $63K | Sell |
450
-100
| -18% | -$14K | ﹤0.01% | 302 |
|
|
2020
Q3 | $83.5K | Sell |
550
-95
| -15% | -$14.4K | 0.01% | 228 |
|
|
2020
Q2 | $113K | Buy |
645
+40
| +7% | +$7.02K | 0.02% | 196 |
|
|
2020
Q1 | $86.2K | Hold |
605
| – | – | 0.02% | 206 |
|
|
2019
Q4 | $87.1K | Buy |
605
+55
| +10% | +$7.92K | 0.01% | 242 |
|
|
2019
Q3 | $54K | Buy |
+550
| New | +$54K | 0.01% | 269 |
|